Biomerica, Inc. (NASDAQ:BMRA) Sees Significant Increase in Short Interest

Biomerica, Inc. (NASDAQ:BMRA) saw a large growth in short interest in the month of August. As of August 15th, there was short interest totaling 427,700 shares, agrowthof732.1% from the July 31st total of 51,400 shares. Based on an average daily trading volume, of 677,800 shares, the short-interest ratio is presently 0.6 days. Approximately18.6% of the company’s stock are sold short. Approximately18.6% of the company’s stock are sold short. Based on an average daily trading volume, of 677,800 shares, the short-interest ratio is presently 0.6 days.

Biomerica Stock Down 4.0%

BMRA stock traded down $0.13 during midday trading on Tuesday, hitting $3.01. The company’s stock had a trading volume of 26,787 shares, compared to its average volume of 621,600. Biomerica has a 52-week low of $2.08 and a 52-week high of $10.16. The firm has a market capitalization of $7.66 million, a P/E ratio of -1.30 and a beta of 0.35. The firm has a 50-day simple moving average of $3.28 and a 200-day simple moving average of $3.93.

Hedge Funds Weigh In On Biomerica

A hedge fund recently bought a new stake in Biomerica stock. Bulltick Wealth Management LLC purchased a new stake in Biomerica, Inc. (NASDAQ:BMRA) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 137,149 shares of the company’s stock, valued at approximately $78,000. Bulltick Wealth Management LLC owned 5.39% of Biomerica as of its most recent SEC filing. Hedge funds and other institutional investors own 22.28% of the company’s stock.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.